Skip to main content

Hypertension News (Page 10)

Andexanet Yields Better Control of Hematoma Expansion Than Usual Care

FRIDAY, May 17, 2024 – For patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which reverses the effects of factor Xa...

New Blood Test Could Help Spot Preeclampsia in First Trimester

WEDNESDAY, May 15, 2024 – Preeclampsia can be a life-threatening complication of pregnancy, but a new blood test can help predict a woman's risk for the condition while she is in her first...

Blood Pressure Down With Self-Monitoring of BP, Self-Titration of Medications

FRIDAY, May 10, 2024 – Blood pressure (BP) self-monitoring, together with self-titration of antihypertensive medications, is associated with a reduction in BP, according to a study published online...

About 90% of U.S. Adults Are On the Way to Heart Disease

WEDNESDAY, May 8, 2024 – Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds, and almost 10% have the disease already....

Long-Term Risk for MACE Increased for Children With Hypertension

TUESDAY, May 7, 2024 – The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May 6 in JAMA...

Novel Genetic Loci ID'd for Hypertension in European Ancestry

TUESDAY, May 7, 2024 – A total of 113 novel genetic loci have been identified in the largest single-stage common variant genome-wide association study of blood pressure (BP) reported to date,...

New Test Might Alert Pregnant Women to Preeclampsia Danger

MONDAY, May 6, 2024 – A potentially dangerous spike in blood pressure known as preeclampsia can occur in 1 in every 25 pregnancies, but an accurate test to spot those women at highest risk has...

FDA Approves Tryvio (aprocitentan) for the Combination Treatment of Resistant Hypertension

RADNOR, Pa., March 20, 2024 /PRNewswire/ – Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Administration (FDA) has approved Tryvio™ (aprocitentan) for the treatment of h...

FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease

February 28, 2022 - The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution for the treatment of: Hypertension in adults and children 6 years and older, to lower blood...

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older

WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, ann...

FDA Medwatch Alert: Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)

As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level....

FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain

TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...

FDA Medwatch Alert: Labetalol Hydrochloride Injection by Hospira: Recall - Potential For Cracked Glass At Rim Surface Of Vials

ISSUE: Hospira is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus (NDC...

Medicure Announces FDA Approval Received for Prexxartan (valsartan) Oral Solution

WINNIPEG, Dec. 19, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced that Carmel Biosciences, Inc. ("Carmel") has...

Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older

DUBLIN, Nov. 15, 2017 /PRNewswire/ – Noden Pharma DAC, a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas,...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, amlodipine, propranolol, losartan, hydrochlorothiazide, atenolol, spironolactone, clonidine, view more... carvedilol, Metoprolol Succinate ER, diltiazem, Bystolic, Lasix, Metoprolol Tartrate, furosemide, bisoprolol, valsartan, Norvasc, ramipril, guanfacine, prazosin, verapamil, Benicar, Diovan, minoxidil, nifedipine, nitroglycerin, Coreg